Table 4.
Cells/μL | Phenotype | Pre-exercise | Post-exercise | 30-min post-exercise | %Δ pre- to post-exercise | Effect of time |
---|---|---|---|---|---|---|
Plasma cells | CD38brightCD138+ | 2.6 ± 5.6 | 5.4 ± 12.6 | 2.9 ± 6.2 | 58 ± 41 | F(1.00,7.00) = 1.25, p = 0.30, ηp2 = 0.15 |
CD38brightCD138+CD45−/dimCD19− (with light-chain restriction) | 2.1 ± 5.5 | 4.7 ± 12.3 | 2.3 ± 6.1 | 121 ± 95 | F(1.00,7.00) = 1.18, p = 0.31, ηp2 = 0.14 | |
CD38brightCD138+CD45+CD19+ (with polyclonal light chains) | 0.33 ± 0.19 | 0.33 ± 0.19 | 0.33 ± 0.20 | 9 ± 41 | F(2,14) = 0.01, p = 0.99, ηp2 = 0.001 | |
B-cells | CD19+ | 100 ± 80 | 121 ± 84b | 100 ± 87c | 32 ± 34 | F(2,14) = 11.60, p = 0.001, ηp2 = 0.62 |
CD19+CD20+ | 99 ± 80 | 120 ± 84b | 99 ± 87c | 33 ± 35 | F(2,14) = 11.56, p = 0.001, ηp2 = 0.62 | |
CD19+CD20+CD27−CD38+ | 50 ± 52 | 57 ± 57a | 47 ± 55c | 28 ± 36 | F(2,14) = 9.96, p = 0.002, ηp2 = 0.59 | |
CD19+CD20+CD27+CD38+ | 33 ± 32 | 39 ± 33a | 36 ± 34 | 30 ± 28 | F(2,14) = 3.94, p = 0.044, ηp2 = 0.36 | |
CD19+CD20+CD27+CD38− | 9.1 ± 5.6 | 14 ± 8.4a | 10 ± 6.6 | 52 ± 46 | F(2,14) = 7.10, p = 0.007, ηp2 = 0.50 | |
CD19+CD20+Ig-Kappa | 60 ± 49 | 75 ± 53b | 60 ± 54d | 36 ± 36 | F(2,14) = 13.30, p < 0.001, ηp2 = 0.66 | |
CD19+CD20+Ig-lambda | 38 ± 30 | 44 ± 30 | 38 ± 32 | 27 ± 35 | F(2,14) = 3.64, p = 0.053, ηp2 = 0.34 |
ANOVA, analysis of variance. Clonal plasma cells were phenotyped as CD38brightCD138+CD45−/dimCD19− with light-chain restriction and polyclonal plasma cells were phenotyped as CD38brightCD138+CD45+CD19+ with polyclonal light chains. Transitional-like B-cells were phenotyped as CD19+CD20+CD27−CD38+, plasma blasts were phenotyped as CD19+CD20+CD27+CD38+, and memory B-cells were phenotyped as CD19+CD20+CD27+CD38−.
indicates a significant difference from pre-exercise at p < 0.05.
indicates a significant difference from pre-exercise at p < 0.01.
indicates a significant difference from post-exercise at p < 0.05.
indicates a significant difference from post-exercise at p < 0.01.